期刊文献+

大剂量山莨菪碱救治老年重症感染性休克3例报告并文献复习 被引量:7

Treatment of severe septic shock with anisodamine: a retrospective study of 3 aged cases
暂未订购
导出
摘要 目的 探讨老年重症感染性休克的治疗方法。方法 总结3例老年重症感染性休克的治疗过程。结果 3例患者中,男性2例,女性1例,年龄72~86岁,均合并有>3种基础疾病,2例为手术后合并感染性休克,1例为急性心肌梗死后合并感染性和心原性休克,在常规抗休克治疗无效的情况下,加用山莨菪碱(654-2)20mg静脉注射,5~10min1次,休克均得到纠正,应用山莨菪碱总量为780~1700mg。结论 老年重症感染性休克晚期患者在常规抗休克治疗无效时,短时间内大剂量应用山莨菪碱治疗可以收到良好的效果。本疗法可应用于SARS老年重症感染性休克患者。 Objective To explore the treatment methods of severe septic shock in the elderly. Methods The therapy of three aged cases of severe septic shock was reviewed. Results Three cases, two males and one female aged 72-86,had more than 3 underlying diseases. Severe septic shock occurred after operation in 2 cases and acute myocardial infarction in 1 case. All cases did not respond to the routine anti-shock treatment, but the shock was corrected after receiving anisodamine(654-2) 20mg iv every 5-10min. The total dosage of anisodamme was from 780mg to 1 700mg. Conclusions It may be a good choice to give big dosage of anisodamine therapy to the aged patients with severe septic shock when the routine anti-shock therapy was inefficacious. This method can be applicated for late eldery SARS patients with severe septic shock.
出处 《中华老年多器官疾病杂志》 2003年第2期102-104,共3页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 重症感染性休克 山茛菪碱 救治 老年人 治疗 aged septic shock anisodamine (654-2) treatment
  • 相关文献

参考文献3

二级参考文献9

共引文献14

同被引文献59

  • 1陈孝治.长托宁[J].中南药学,2003,1(3):188-189. 被引量:69
  • 2林小鸿,蒋龙元,罗克勤,叶华.感染性休克病死率和危险因素分析[J].岭南急诊医学杂志,2004,9(4):244-245. 被引量:13
  • 3韩继媛,曹锋生,王一镗,茅志诚.长托宁的临床应用[J].中华急诊医学杂志,2005,14(2):173-174. 被引量:257
  • 4王子骥,徐有青,卢青,王颖.肝损伤模型家兔的微循环障碍山莨菪碱治疗作用的实验研究[J].中华传染病杂志,1997,15(1):36-37. 被引量:21
  • 5黄林帮 申力 等.别嘌呤醇、山莨菪碱对大鼠应激性损伤的保护作用[J].中国病理生理杂志,1994,10:257-257,269.
  • 6曾繁忠.新药长托宁研究和应用概况论文集[M].四川:成都科技出版社,2002.4-14.
  • 7Zhang JT.New drugs derived from medicinal plants[ J ].Therapie,2002,57:137-150.
  • 8Su JY.Cell protection mechanism of antishock action of anisodamine[J].Chin Med J(Engl),1992,105:976-979.
  • 9Ruan QR,Zhang WJ,Hufnagl P,et al.Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells:contribution of the NF-kappa B pathway[J].J Vasc Res,2001,38:13-19.
  • 10[3]Su JY.Cell protetion mechanism of antishock action of anisodamine[J].Chin Med J(Engl),1992,105:976-979.

引证文献7

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部